Bitcoin vs Enzyme — how do they compare? Bitcoin trades at Rp1,121,815,230 (market cap Rp22.516,9T, Rp334,63T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Bitcoin is far larger — about 167873704.6× Enzyme's market cap, and Bitcoin's supply is capped (20,1M / 21M BTC (96%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bitcoin for 107 Days and Enzyme for 29 Days on average.
| BTC | MLN | |
|---|---|---|
Market Cap | Rp22.516,9T | Rp134,13M |
Volume (24h) | Rp334,63T | Rp104,56M |
Circulating Supply | 20,1M / 21M BTC (96%) | 3,3M MLN |
Typical Hold Time | 107 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Bitcoin is currently trading at Rp1,130,046,171 with a market cap of Rp22.65 trillion, showing a bearish technical signal as indicated by moving averages. The asset is near its max supply with 96% in circulation, and the average hold time is 107 days. Recent news highlights long-term bullish sentiment from figures like Fred Krueger, though short-term volatility persists amid macroeconomic concerns.
Overall outlook is cautious with neutral oscillators suggesting potential stabilization. Key opportunities include long-term growth projections up to $1 million by 2030, while major risks involve high volatility, regulatory pressures, and recent 50% price corrections. Investors should monitor support at Rp1,103,783,831 and resistance at Rp1,143,035,269.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
A crypto asset founded in January 2009 by Satoshi Nakamoto. It is the first and most widely used decentralized online currency with the highest market capitalization. Its purpose is to provide a peer-to-peer payment system without the need of third party. The total supply of BTC is limited and pre-defined at 21 million. As of October 2020, there are more than 85% of BTC in circulation.
Read more on BTC →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →